5551 - 5600 of 5857 Results
Title
Year
- Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?2011OPENTitle: Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 5Start Page: 365End Page: 371Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.02.017Best OA location URL: https://europepmc.org/articles/pmc3109165?pdf=renderCitation Count: 49
-
OPENTitle: Transcription Factor-Induced Lineage Selection of Stem-Cell-Derived Neural Progenitor CellsJournal Name: Cell Stem CellPublisher: Elsevier BVVol: 8Issue #: 6Start Page: 663End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.stem.2011.04.001Best OA location URL: http://www.cell.com/article/S1934590911001664/pdfCitation Count: 69
-
OPENTitle: Stress and the risk of multiple sclerosisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 22Start Page: 1866End Page: 1871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31821d74c5Best OA location URL: https://europepmc.org/articles/pmc3115807?pdf=renderCitation Count: 65
- Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice2011OPENTitle: Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent miceJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 47Issue #: 4Start Page: 286End Page: 292Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2011.05.006Best OA location URL: https://europepmc.org/articles/pmc3149813?pdf=renderCitation Count: 47
-
OPENTitle: Neurochemical phenotypes of myenteric neurons in the rhesus monkeyJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 519Issue #: 17Start Page: 3387End Page: 3401Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.22679Best OA location URL: https://europepmc.org/articles/pmc4033411?pdf=renderCitation Count: 24
-
OPENTitle: Mood and cognition in leucine‐rich repeat kinase 2 G2019S Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 10Start Page: 1875End Page: 1880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23746Best OA location URL: https://europepmc.org/articles/pmc3972755?pdf=renderCitation Count: 40
- Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease2011OPENTitle: Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 11Start Page: 2051End Page: 2057Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23792Best OA location URL: https://europepmc.org/articles/pmc3168697?pdf=renderCitation Count: 80
-
OPENTitle: β-Hexachlorocyclohexane levels in serum and risk of Parkinson's diseaseJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 640End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.04.002Best OA location URL: https://doi.org/10.1016/j.neuro.2011.04.002Citation Count: 54
-
OPENTitle: Repeatability of Aerobic Capacity Measurements in Parkinson DiseaseJournal Name: Medicine & Science in Sports & ExercisePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 43Issue #: 12Start Page: 2381End Page: 2387Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1249/mss.0b013e31822432d4Best OA location URL: https://journals.lww.com/acsm-msse/fulltext/2011/12000/repeatability_of_aerobic_capacity_measurements_in.20.aspxCitation Count: 45
-
OPENTitle: A family with parkinsonism, essential tremor, restless legs syndrome, and depressionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 19Start Page: 1623End Page: 1630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318219fb42Best OA location URL: https://europepmc.org/articles/pmc3100088?pdf=renderCitation Count: 28
-
OPENTitle: Parkinson's disease, cortical dysfunction, and alpha‐synucleinJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1436End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23697Best OA location URL: https://europepmc.org/articles/pmc3154995?pdf=renderCitation Count: 23
-
OPENTitle: Abnormal calcium homeostasis and protein folding stress at the ERJournal Name: Communicative & Integrative BiologyPublisher: Informa UK LimitedVol: 4Issue #: 3Start Page: 258End Page: 261Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.4161/cib.4.3.15019Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/cib.4.3.15019?needAccess=true&role=buttonCitation Count: 37
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures2011OPENTitle: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 5Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2Best OA location URL: https://europepmc.org/articles/pmc3376651?pdf=renderCitation Count: 261
- Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease2011OPENTitle: Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 122Issue #: 1Start Page: 49End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-011-0831-1Best OA location URL: https://europepmc.org/articles/pmc3362487?pdf=renderCitation Count: 89
-
OPENTitle: Group patient visits for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 18Start Page: 1542End Page: 1547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182194badBest OA location URL: https://europepmc.org/articles/pmc3100128?pdf=renderCitation Count: 22
- Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations2011OPENTitle: Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1781End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23655Best OA location URL: https://europepmc.org/articles/pmc3142314?pdf=renderCitation Count: 18
- Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion2011OPENTitle: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusionJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 124Issue #: 9Start Page: 1403End Page: 1410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/jcs.079293Best OA location URL: https://europepmc.org/articles/pmc3078809Citation Count: 71
- Probable RBD is increased in Parkinson’s disease but not in essential tremor or restless legs syndrome2011OPENTitle: Probable RBD is increased in Parkinson’s disease but not in essential tremor or restless legs syndromeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 6Start Page: 456End Page: 458Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.03.007Best OA location URL: https://europepmc.org/articles/pmc3119772?pdf=renderCitation Count: 78
-
OPENTitle: A Genome‐Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6Journal Name: Annals of Human GeneticsPublisher: WileyVol: 75Issue #: 3Start Page: 351End Page: 358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1469-1809.2011.00643.xBest OA location URL: https://europepmc.org/articles/pmc3077806?pdf=renderCitation Count: 10
-
OPENTitle: Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar DegenerationJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 68Issue #: 4Start Page: 488End Page: 488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2011.53Best OA location URL: https://europepmc.org/articles/pmc3160280?pdf=renderCitation Count: 114
- Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposure2011OPENTitle: Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposureJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 15Start Page: 1296End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182152830Best OA location URL: https://europepmc.org/articles/pmc3090062?pdf=renderCitation Count: 82
-
OPENTitle: Methylphenidate for gait impairment in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 14Start Page: 1256End Page: 1262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182143537Best OA location URL: https://europepmc.org/articles/pmc3068005?pdf=renderCitation Count: 89
- Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease2011OPENTitle: Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 33Issue #: 9Start Page: 1598End Page: 1610Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1460-9568.2011.07660.xBest OA location URL: https://europepmc.org/articles/pmc3086951?pdf=renderCitation Count: 118
-
OPENTitle: Molecular insights into Parkinson's diseaseJournal Name: F1000 Medicine ReportsPublisher: Faculty Opinions LtdVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3410/m3-7Best OA location URL: https://connect.h1.co/prime/reports/m/3/7/pdfCitation Count: 52
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy2011OPENTitle: Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System AtrophyJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 178Issue #: 4Start Page: 1509End Page: 1516Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajpath.2011.01.006Best OA location URL: http://ajp.amjpathol.org/article/S0002944011000575/pdfCitation Count: 108
- Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue2011OPENTitle: Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain TissueJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 26Issue #: 1Start Page: 8End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0b013e31821300bcBest OA location URL: https://europepmc.org/articles/pmc3286131?pdf=renderCitation Count: 125
-
OPENTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://europepmc.org/articles/pmc3140626?pdf=renderCitation Count: 7
-
OPENTitle: S-Nitrosylation of ApoE in Alzheimer’s DiseaseJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 50Issue #: 17Start Page: 3405End Page: 3407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/bi200266vBest OA location URL: https://europepmc.org/articles/pmc3082618?pdf=renderCitation Count: 39
- Tremor severity and age: A cross‐sectional, population‐based study of 2,524 young and midlife normal adults2011OPENTitle: Tremor severity and age: A cross‐sectional, population‐based study of 2,524 young and midlife normal adultsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1515End Page: 1520Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23674Best OA location URL: https://europepmc.org/articles/pmc5927551?pdf=renderCitation Count: 12
- Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?2011OPENTitle: Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?Journal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 69Issue #: 2Start Page: 357End Page: 361Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3182160456Best OA location URL: https://europepmc.org/articles/pmc3593636?pdf=renderCitation Count: 23
-
OPENTitle: Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 7Issue #: 4Start Page: 436End Page: 444Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2010.08.228Best OA location URL: https://europepmc.org/articles/pmc3117084?pdf=renderCitation Count: 127
-
OPENTitle: Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2Journal Name: Nature Chemical BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 203End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nchembio.538Best OA location URL: https://europepmc.org/articles/pmc3287420?pdf=renderCitation Count: 414
-
OPENTitle: Personality Characteristics and Motor Skills Attributed to Occupations in Parkinson DiseaseJournal Name: Cognitive and Behavioral NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 24Issue #: 1Start Page: 18End Page: 25Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnn.0b013e318218c5ebBest OA location URL: https://europepmc.org/articles/pmc3656654?pdf=renderCitation Count: 16
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease2011OPENTitle: Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 1048End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.11Best OA location URL: http://www.cell.com/article/S1525001616319098/pdfCitation Count: 134
- Solution-Phase Parallel Synthesis and SAR of Homopiperazinyl Analogs as Positive Allosteric Modulators of mGlu42011OPENTitle: Solution-Phase Parallel Synthesis and SAR of Homopiperazinyl Analogs as Positive Allosteric Modulators of mGlu4Journal Name: ACS Combinatorial SciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 2Start Page: 159End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/co1000508Best OA location URL: https://europepmc.org/articles/pmc3057427?pdf=renderCitation Count: 7
- β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling Pathway2011OPENTitle: β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling PathwayJournal Name: The Journal of ImmunologyPublisher: Oxford University Press (OUP)Vol: 186Issue #: 7Start Page: 4443End Page: 4454Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.1002449Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/186/7/4443/1340946/1002449.pdfCitation Count: 109
- Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients2011OPENTitle: Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 3Start Page: 930End Page: 940Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci43871Best OA location URL: http://www.jci.org/articles/view/43871/files/pdfCitation Count: 151
-
OPENTitle: In vivo demonstration that α-synuclein oligomers are toxicJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 108Issue #: 10Start Page: 4194End Page: 4199Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1100976108Best OA location URL: https://europepmc.org/articles/pmc3053976?pdf=renderCitation Count: 1373
-
OPENTitle: MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 7Start Page: 670End Page: 672Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820c30c1Best OA location URL: https://europepmc.org/articles/pmc3053340?pdf=renderCitation Count: 72
-
OPENTitle: Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 5Start Page: 885End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23644Best OA location URL: https://europepmc.org/articles/pmc3082617?pdf=renderCitation Count: 35
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease2011OPENTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/search/files/1732507/1885514.pdfCitation Count: 162
- Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms2011OPENTitle: Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanismsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 121Issue #: 6Start Page: 705End Page: 719Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00401-011-0806-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-011-0806-2.pdfCitation Count: 58
-
OPENTitle: Mitochondrial DNA haplogroups and mutations in children with acquired central demyelinationJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 9Start Page: 774End Page: 780Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820ee1bbBest OA location URL: https://europepmc.org/articles/pmc3053335?pdf=renderCitation Count: 17
-
OPENTitle: Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 18Issue #: 5Start Page: 756End Page: 765Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1468-1331.2011.03353.xBest OA location URL: https://europepmc.org/articles/pmc3556904?pdf=renderCitation Count: 110
-
OPENTitle: Essential tremor and Parkinson's disease: Lack of a linkJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 3Start Page: 372End Page: 377Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23509Best OA location URL: https://europepmc.org/articles/pmc3070808?pdf=renderCitation Count: 61
- Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in Rats2011OPENTitle: Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in RatsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 1106End Page: 1110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm101271sBest OA location URL: https://europepmc.org/articles/pmc3166797?pdf=renderCitation Count: 47
-
OPENTitle: Use of Florbetapir-PET for Imaging β-Amyloid PathologyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 305Issue #: 3Start Page: 275End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2010.2008Best OA location URL: https://europepmc.org/articles/pmc7041965?pdf=renderCitation Count: 1018
- α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells2011OPENTitle: α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cellsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 2Start Page: 715End Page: 725Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci43366Best OA location URL: http://www.jci.org/articles/view/43366/files/pdfCitation Count: 772
- Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease2011OPENTitle: Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 25Issue #: 4Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.10-173625Best OA location URL: https://europepmc.org/articles/pmc3058704Citation Count: 126
- Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats2011OPENTitle: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 6Start Page: 861End Page: 868Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032Best OA location URL: https://europepmc.org/articles/pmc3133531?pdf=renderCitation Count: 71